-
27Zennova and Rapafusyn Announce Strategic Collaboration to Advance Non-Degrading Molecular Glue Drug Development
BioCarier® Technology Platform to Accelerate RapaGlue™ Drug Development
-
21Zennova Achieves Key Regulatory Milestone with FDA Inspection
-Chengdu Manufacturing Facility Successfully Completes FDA cGMP Inspection
-
26Zennova New Drug Development Achieved Breakthrough Clinical Results using BioCarier® Technology Platform
ZennovaPharmaceuticalsrecentlyannouncedsignificantadvancementsinitsinnovativeleukemiadrug,Zenno-10,basedonitsproprietarysingle-nanodrugdeliveryplatform,BioCarier®.Thelatesthumanclinicaltrialshaved...
-
22Zennova Pharmaceuticals (Chengdu) Co., Ltd. Successfully Passes Sichuan MPA's On-site Pharmaceutical Production License GMP Inspection
March7-8,2025–ZennovaPharmaceuticals(Chengdu)Co.,Ltd.(hereinafterreferredtoas"Zennova")successfullypassed its on-site GMPquality inspectionforthePharmaceuticalProductionLicen...
-
08Zennova Pharma Group’s China facility in production!
Zennova Pharma Group’s China facility is in production recently. Its 350,000 SQF state-of- the-art cGMP facility will support US & global markets for various of Rx products.
-
24Zennova Pharmaceutical partners with Innogenix Pharmaceuticals
Zennova PharmaceuticalrecentlyannouncedapartnershipwithInnogenix,aleadingpharmaceuticalcompanydintheUnitedStates.ThecollaborationgrantsZennovavariesofrightstoaccesstencutting-edgeRxproductsdevel...
-
24Zennova Pharma Group Completes Nearly 100 Million Yuan Series B Fundraising
Zennova Pharma Group recently achieved a significant milestone by successfully completing a Series B fundraising round of over 15 million dollars.
-
13Zennova Pharmaceutical’ Manufacturing Plant and R&D Center Interior Construction Project Opening Ceremony was Held in Chengdu, China
At the start of the new year and on the morning of January 11, 2023, the groundbreaking ceremony for Zennova Pharmaceutical’ manufacturing plant and R&D center interior construction project was held